| Marisa Aspromonti, MA | |
|
800 Connecticut Blvd Fl 4, East Hartford, CT 06108-3239 | |
| (860) 569-5900 | |
| Not Available |
| Full Name | Marisa Aspromonti |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 800 Connecticut Blvd Fl 4, East Hartford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235715491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Entity Name | Intercommunity Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073548533 PECOS PAC ID: 9032001649 Enrollment ID: O20040329000218 |
News Archive
High levels of microscopic, soot-like particles are increasing the risk of premature death for millions of people, including those with heart or lung disease, according to the American Lung Association State of the Air: 2004 report released today.
Doctors have noticed a pattern in performing bone marrow transplants as a cure for diseases involving bone marrow failure: more transfusions before a bone marrow transplant correlates with a higher likelihood of rejection, says James Zimring, MD, PhD, assistant professor of pathology and laboratory medicine at Emory University School of Medicine.
The new study points to promising new directions using a known therapeutic strategy for Alzheimer's disease—a disorder that will affect nearly 14 million Americans by 2050, according to the Alzheimer's Association...
Simulations Plus, Inc.,a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of Version 7.0 of GastroPlus, the industry's gold standard software for the simulation of drug absorption, pharmacokinetics, and pharmacodynamics.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marisa Aspromonti, MA 270 Farmington Ave Ste 328, Farmington, CT 06032-1909 Ph: (866) 887-6864 | Marisa Aspromonti, MA 800 Connecticut Blvd Fl 4, East Hartford, CT 06108-3239 Ph: (860) 569-5900 |
News Archive
High levels of microscopic, soot-like particles are increasing the risk of premature death for millions of people, including those with heart or lung disease, according to the American Lung Association State of the Air: 2004 report released today.
Doctors have noticed a pattern in performing bone marrow transplants as a cure for diseases involving bone marrow failure: more transfusions before a bone marrow transplant correlates with a higher likelihood of rejection, says James Zimring, MD, PhD, assistant professor of pathology and laboratory medicine at Emory University School of Medicine.
The new study points to promising new directions using a known therapeutic strategy for Alzheimer's disease—a disorder that will affect nearly 14 million Americans by 2050, according to the Alzheimer's Association...
Simulations Plus, Inc.,a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of Version 7.0 of GastroPlus, the industry's gold standard software for the simulation of drug absorption, pharmacokinetics, and pharmacodynamics.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 8 days ago
Bernisha La'salle Williams, LPC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 61 Alps Dr, East Hartford, CT 06108 Phone: 860-569-5900 | |
Shawn Dougherty, MS, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 490 Silver Ln, East Hartford, CT 06118 Phone: 860-593-3902 | |
Jordan Giambattista, Counselor Medicare: Not Enrolled in Medicare Practice Location: 474r School St, East Hartford, CT 06108 Phone: 860-730-8811 Fax: 860-731-5536 | |
Lynnell Brown, LADC Counselor Medicare: Medicare Enrolled Practice Location: 50 Hillside St Apt A3, East Hartford, CT 06108 Phone: 860-997-0851 | |
Glenroy Patrick Patterson, BCBA Counselor Medicare: Not Enrolled in Medicare Practice Location: 72 Birchwood Rd, East Hartford, CT 06118 Phone: 860-206-9884 Fax: 860-812-2399 | |
Tangie R Mcdougald, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 Burnside Ave, East Hartford, CT 06108 Phone: 860-282-8882 Fax: 860-282-8890 | |
Emrullah Kiydal, Counselor Medicare: Not Enrolled in Medicare Practice Location: 474r School St, East Hartford, CT 06108 Phone: 860-730-8811 |